Nucleic Acid-Targeted Therapeutics (Room 206AB)

Sponsored By 

Session Chair - Not Funded(s)

• DR

  Dominic Reynolds, PhD (he/him/his)

  Remix Therapeutics, Massachusetts, United States

Presentations:

• 10:00 AM – 10:30 AM EST

  Small molecule proximity-induced targeted RNA degraders as research tools and antiviral agents
  

  Sigitas Mikutis, PhD – University of Cambridge
• 10:30 AM – 11:00 AM EST

  Oligonucleotide modalities in RNA Therapeutics: the critical steps of target Identification and oligonucleotide design in drug discovery
  

  Konstantina Skourti-Stathaki, PhD (she/her/hers) – N-Lorem Foundation
• 11:00 AM – 11:30 AM EST

  Expansions of Friedreich's ataxia GAA•TTC repeats: role of DNA replication and prevention by LNA-DNA oligonucleotides
  

  Sergei Mirkin, PhD (he/him/his) – Tufts University
• 11:30 AM – 12:00 PM EST

  Reprogramming RNA to target unaddressed disease drivers
  

  Dominic Reynolds, PhD (he/him/his) – Remix Therapeutics